ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106969 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106969; 2) Community: the network communities that were significantly associated with the response to NSC 106969; 3) Molecule: the relationships between components within communities and NSC 106969; 4) MDR: the compounds that were significantly associated with the NSC 106969.

NSC Compound Enrichment Correlation
NSC 744025 diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate 0.0385067071027345 0.29319179
NSC 79563 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine 0.0385067071027345 0.14690288
NSC 374998 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2-pyrimidinyl)ethylidene] hydrazide 0.0385203205529754 0.027577923
NSC 105023 RUBIFLAVIN 0.0385203205529756 0.14701739
NSC 110383 Naphtho[1,2-c]quinolizinium, 13-methyl-, chloride 0.0385203205529759 0.010771754
NSC 111135 Null 0.0385203205529759 0.32306743
NSC 163062 TRIPTOLIDE 0.0385203205529759 0.056008321
NSC 170983 R 5147 0.0385203205529759 -0.33084902
NSC 225112 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- 0.0385203205529759 0.24622363
NSC 237538 2,4-Thiazolidinedione, 5-(3-phenyl-2-propenylidene)- 0.0385203205529759 0.29113302
Total:95  Current:75    [First] [Prev] [Next] [Last]